Interleukin-4 enzyme-linked immunospot assay may be useful for diagnosing sensitization to house dust mite
Background The skin prick test (SPT) is considered a standard test for identification of allergens, but it has some limitations in clinical practice. The multiple allergen simultaneous test (MAST), which measures allergen‐specific immunoglobulin E in patients’ serum, is a widely used alternative tes...
Saved in:
Published in | International forum of allergy & rhinology Vol. 6; no. 10; pp. 1007 - 1012 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Blackwell Publishing Ltd
01.10.2016
Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Background
The skin prick test (SPT) is considered a standard test for identification of allergens, but it has some limitations in clinical practice. The multiple allergen simultaneous test (MAST), which measures allergen‐specific immunoglobulin E in patients’ serum, is a widely used alternative test, but is limited by its relatively low sensitivity and specificity. As a novel diagnostic test to identify allergens, we investigated the sensitivity and specificity of an interleukin‐4 (IL‐4) enzyme‐linked immunospot (ELISpot) assay for Dermatophagoides farinae (Der f) and Dermatophagoides pteronyssinus (Der p).
Methods
Based on the symptoms and SPT results, 43 house dust mite (HDM) allergic rhinitis (AR) patients and 41 control subjects were included. Peripheral blood was drawn from each subject for IL‐4 ELISpot assay and MAST. The receiver operating characteristic (ROC) curve analysis was conducted to determine the cutoff values. Sensitivity, specificity, and positive and neg predictive values were compared between the 2 tests.
Results
The sensitivity, specificity, and areas under the ROC curve (AUCs) of the IL‐4 ELISpot assay were 88.4%, 97.6%, and 0.939 for Der f, and 95.3%, 97.5%, and 0.971 for Der p, respectively. However, the sensitivity, specificity, and AUC of MAST were 76.7%, 73.2%, and 0.777 for Der f, and 69.8%, 75.6%, and 0.788 for Der p, respectively.
Conclusion
The IL‐4 ELISpot assay showed higher sensitivity, specificity, and AUC than MAST, which indicates its clinical feasibility for diagnosing allergy for HDM. A further study is needed to determine the accuracy of the IL‐4 ELISpot assay for other common allergens. |
---|---|
Bibliography: | Gyeongsang National University Hospital ark:/67375/WNG-MRT3Q7GW-G ArticleID:ALR21786 Ministry of Health and Welfare - No. HI13C13590000 Institute of Health Sciences - No. GNU-2013-02 istex:DF3A46B08B7288C7C8B9A8A56E1295F7055016F6 Korean Health Technology R&D Project Potential conflict of interest: None provided. Funding sources for the study: Clinical Research Fund of Gyeongsang National University Hospital (GNUHCRF‐2013‐0001); Institute of Health Sciences (IHS GNU‐2013‐02); Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (HI13C13590000). ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ISSN: | 2042-6976 2042-6984 2042-6984 |
DOI: | 10.1002/alr.21786 |